The Efficacy of Vitamin E in the Treatment of Tardive Dyskinesia: A Double-Blind Placebo Controlled Study

Mehmud Yucel Agargun, Mecid Caliskan, Melek Soner, Fikret Aysal, Latif Alpkan

Abstract


DOI: http://dx.doi.org/10.5915/26-2-16367

Our aim in this study was to investigate the efficacy of vitamin E in the treatment of tardive dyskinesia in a group of chronic schizophrenic patients. Thirty-eight chronic schizophrenic inpatients with tardive dyskinesia were selected for a double-blind trial of Vitamin E versus placebo (Vitamin E: N=18). Tardive dyskinesia was rated by a blind-trained rater using the Abnormal Involuntary Movement Scale (AIMS) at baseline and after treatment. The AIMS scores in the Vitamin E cohort decreased significantly after treatment while the AJMS scores in the placebo cohort were not different after placebo. The results replicate the short-term effectiveness of Vitamin E in the treatment of tardive dyskinesia in a larger group of chronic schizophrenic patients.


Keywords


Vitamin E; Antioxidant therapy; Tardive dyskinesia; Neuroleptic medication; Chronic schizophrenia

Full Text:

PDF

References


Jeste DV, Wyatt RJ: Understanding and treating tardive dyskinesia. New York: Euilford Press 1982.

Cohen G. Oxyradical toxicity in catecholamine neurons. Neurotoxicology. 1984;5:77-82.

Mackay AUP, Iverson LL, Rossor M, et al. Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry. 1982;39:991-7.

Cadenos E, Ginsberg M, et al. Examination of alphatocopherol antioxidant activity. Biochem J. 1986;723:755-9.

Jackson LV, Przedborski S, Kostic V et al. Partial attenuation of chronic fluphenazine-induced changes in regional monoamine metabolism by D-alpha tocopherol in rat brains. Brain Res Bull. 1991;26(2):251-8.

Oske FA. Vitamin E, a radical defense. N Engl J Med. 1980;303:454-5.

Machlin LJ. Use and safety of elevated dosages of vitamin E in adults. Int J Vitam Nutr Res Suppl. 1989;30:56-68.

Elkashef AM, Ruskin PE, Bacher N, Barrett. Vitamin E in the treatment of tardive dyskinesia. Am J Psychiatry. 1990;147:505-6.

Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry. 1982;39:486-7.

Guy W (ed). ECDEU Assessment Manual for Psychopharmacology: Publication ADM76-338. Washington, DC: US Department of Health, Education, and Welfare;1976:534-537.

Lohr JB, Cadet JL, Lohr MA, et al. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizophr Bull. 1988;14:291-6.

Cadet JL, Lohr JB, Jeste DV.: Free radicals and tardive dyskinsia. Trends in Neuroscience. 1986;9:107-8.

Adler LA, Peselow E, Rosenthal M, el al. Vitamin E treatment of tardive dyskinesia. Biol Psychiatry. 1992;31:61 A-2520.

Shriqui CL, Bradwejn J, Annable L, el al. Vitamin E in the treatment of tardive dyskinesia: A double-blind placebo-controlled study. A J Psychiatry. 1992; 149:391-3.

Egan MF, Hyde TM, Albers W, et al. Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry. 1992;149:773-7.




DOI: https://doi.org/10.5915/26-2-16367




Islamic Medical Association of North America (IMANA) | JIMA and IMANA on Twitter

 

Creative Commons License
This work by Work's author(s) is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.